Cardinal Capital Management Inc (North Carolina)’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.68M | Buy |
101,073
+3,414
| +3% | +$158K | 0.69% | 51 |
|
|
2025
Q1 | $5.96M | Buy |
97,659
+2,625
| +3% | +$160K | 0.92% | 35 |
|
|
2024
Q4 | $5.38M | Buy |
95,034
+353
| +0.4% | +$20K | 0.84% | 40 |
|
|
2024
Q3 | $4.9M | Buy |
+94,681
| New | +$4.9M | 0.76% | 45 |
|
|
2024
Q2 | – | Sell |
-56,860
| Closed | -$3.08M | – | 136 |
|
|
2024
Q1 | $3.08M | Buy |
56,860
+6,210
| +12% | +$337K | 0.5% | 64 |
|
|
2023
Q4 | $2.6M | Buy |
50,650
+15,087
| +42% | +$774K | 0.49% | 68 |
|
|
2023
Q3 | $2.06M | Buy |
35,563
+1,070
| +3% | +$62.1K | 0.42% | 72 |
|
|
2023
Q2 | $2.21M | Buy |
+34,493
| New | +$2.21M | 0.44% | 71 |
|